FDA authorizes updated bivalent COVID-19 booster for children aged 5 and older
(NEW YORK) -- The U.S. Food and Drug Administration authorized the updated bivalent COVID-19 booster for younger children Wednesday.The Pfizer booster has been authorized for children aged 5 and older and the Moderna booster for children aged 6 and older.When the new boosters were... Read More.